Met Life Investment Management, LLC Homology Medicines, Inc. Transaction History

Met Life Investment Management, LLC

$14.7 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.64 - $7.78 $57,286 - $122,441	-15,738 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$6.01 - $8.71 $75,317 - $109,153	12,532 Added 390.89%	15,738 $123,000
Q3 2021 Jun 21, 2023	BUY	$6.01 - $8.71 $94,585 - $137,077	15,738 New	15,738 $123,000
Q3 2021 Mar 22, 2023	BUY	$6.01 - $8.71 $75,317 - $109,153	12,532 Added 390.89%	15,738 $123,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $94,585 - $137,077	15,738 New	15,738 $124,000

Q2 2021 Aug 16, 2021	SELL	$6.02 - $9.64 $19,300 - $30,905	-3,206 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$9.17 - $14.8 $29,399 - $47,448	3,206 New	3,206 $30,000
Q1 2021 Jun 26, 2023	BUY	$9.17 - $14.8 $29,399 - $47,448	3,206 New	3,206 $30.2 Million
Q1 2021 Mar 22, 2023	SELL	$9.17 - $14.8 $116,578 - $188,152	-12,713 Reduced 79.86%	3,206 $30,000
Q1 2021 May 14, 2021	SELL	$9.17 - $14.8 $116,578 - $188,152	-12,713 Reduced 79.86%	3,206 $30,000
Q4 2020 Jun 22, 2023	BUY	$8.92 - $13.29 $141,997 - $211,563	15,919 New	15,919 $179,000
Q3 2020 Jun 26, 2023	BUY	$9.94 - $16.59 $158,234 - $264,096	15,919 New	15,919 $170,000
Q2 2020 May 24, 2024	BUY	$12.07 - $19.34 $192,142 - $307,873	15,919 New	15,919 $242 Million
Q2 2020 Jun 26, 2023	BUY	$12.07 - $19.34 $192,142 - $307,873	15,919 New	15,919 $241,000
Q2 2020 Mar 22, 2023	BUY	$12.07 - $19.34 $47,471 - $76,064	3,933 Added 32.81%	15,919 $241,000
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $47,471 - $76,064	3,933 Added 32.81%	15,919 $242,000
Q1 2020 Jul 12, 2023	BUY	$12.5 - $22.04 $149,825 - $264,171	11,986 New	11,986 $186,000
Q4 2019 Jul 12, 2023	BUY	$11.42 - $22.19 $136,880 - $265,969	11,986 New	11,986 $248,000
Q3 2019 Jul 12, 2023	BUY	$14.74 - $22.28 $176,673 - $267,048	11,986 New	11,986 $216,000
Q3 2019 Mar 22, 2023	BUY	$14.74 - $22.28 $52,415 - $79,227	3,556 Added 42.18%	11,986 $216,000
Q3 2019 Nov 14, 2019	BUY	$14.74 - $22.28 $52,415 - $79,227	3,556 Added 42.18%	11,986 $217,000
Q2 2019 Jul 12, 2023	BUY	$18.35 - $30.34 $219,943 - $363,655	11,986 New	11,986 $234,000
Q1 2019 Jul 13, 2023	BUY	$19.76 - $29.57 $166,576 - $249,275	8,430 New	8,430 $233,000
Q4 2018 Jul 13, 2023	BUY	$18.39 - $26.3 $155,027 - $221,709	8,430 New	8,430 $188,000
Q4 2018 Mar 22, 2023	BUY	$18.39 - $26.3 $155,027 - $221,709	8,430 New	8,430 $188,000
Q4 2018 Feb 14, 2019	BUY	$18.39 - $26.3 $155,027 - $221,709	8,430 New	8,430 $188,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account